DOCSLIB.ORG

Fast Dissolving Films an Innovative Drug Delivery System

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Review Article ISSN 2277-3657 Available online at www.ijpras.com International Journal of Volume 2, issue 1 (2013),14-24 Pharmaceutical Research & Allied Sciences Fast Dissolving Films: An Innovative Drug Delivery System Kaur Mandeep*,A.C. Rana, Seth Nimrata Department of Pharmaceutics, Rayat Institute of Pharmacy, S.B.S.Nagar-144533(Punjab) India *Email id: [email protected] Subject: Pharmaceutics Abstract In the recent years, many of the pharmaceutical groups are focusing their research on rapid dissolving technology. Amongst the plethora of avenues explored for rapid drug releasing product, Fast Dissolving Films technology is gaining much attention. Fast Dissolving Films evolved over the past few years from the confection and oral care markets in the form of breath strips and became a novel and widely accepted form by consumers for delivering vitamins and personal care products. These are solid dosage forms, which disintegrate or dissolve within 1 min when placed in the mouth without drinking water or chewing. This technology has been used for local action, rapid release products. The oral films are formulated using polymers, plasticizer, flavors, colors and sweeteners. This review describes about the formulation methodology, evaluation parameters and the future aspects of fast dissolving films. Keywords: Fast Dissolving Films, Solvent casting technique, Rapid disintegrating, Patented technologies Introduction Oral route of administration is the most delivery markets [2,3]. Pharmaceutical convenient and preferred route of companies and consumers alike have embraced administration among the various other FDFs as a practical and accepted alternative to delivery system. More than 70% of drugs are traditional OTC medicines, such as liquids, available in the market in the form of oral drug tablets and capsules, because of the various delivery system due to pain avoidance and benefits of the films. FDFs offer fast, accurate versatility (to accommodate various types of dosing in a safe, efficacious format that is drug candidates) [1]. Dysphagia is commonly convenient and portable, without requiring the found among all age groups. Due to this use of water or a spoon. A variety of polymers problem, approximately 50% of population, are available for preparation of RDFs. The mainly pediatric and geriatric patients, tend to polymers can be used alone or in combination avoid taking oral solid dosage preparations due to obtain the desired film properties. The films to fear of choking. To overcome various obtained should be tough enough so that they problems related to swallowing, Fast are not damaged while handling or during dissolving Tablets (FDTs) were designed in transportation. On the other hand, Mouth early 19 th century, which slowly led to their dissolving films should have the property to further advancement and thus Fast Dissolving dissolve within seconds when placed in mouth Films (FDFs) were developed. Fast dissolving and deliver the drug to the oral cavity dosage form has become increasingly instantaneously. The excipients employed in important because of their unique properties. FDFs are preferably hydrophilic in nature They quickly disintegrate and dissolve, and whereas drug may be either hydrophilic or can be administered without water, making hydrophobic. As the film forming polymer them particularly suitable for pediatrics and (which forms the platform for the RDFs) and geriatric patients. Fast dissolving films (FDFs), plasticizer are the most essential and major have gained popularity not only in breath strips component of the FDFs, at least 40-50 % w/w but also in personal care, food and drug of polymer and upto 20% (total weight of 14 Available online at www.ijpras.com polymer) of plasticizer should generally be • The drug to be incorporated should have present based on the total weight of dry RDFs. low dose upto 40 mg. Technology Catalysts forecasts the market for • The drugs with smaller and moderate drug products in oral thin film formulations molecular weight are preferable. was valued of $500 million in 2007 and could • Good solubility in water as well as in reach $2billion in 2012. Based on upward saliva and also good stability. global growth trends of the past decade, the Classification of Oral Films [6] fast dissolving dosage market could produce There are three different subtypes of oral revenues of $13billion by 2015[4]. The FDFs films: technology continues to be viewed as an i. Flash release alternative for FDT products that would afford ii. Mucoadhesive melt-away wafer a superior barrier to generic entry and product iii. Mucoadhesive sustained-release wafers differentiation to over ‐the ‐counter brands. Types of oral films and their properties From the marketing perspective, a patented are described in Table 1 ODF technology would be beneficial. The grant of marketing exclusivity to the new dosage form would help to gain more revenue. Classification of Fast Dissolving The various synonyms used for FDFs include Technology mouth dissolving films (MDFs), orally For ease of description, fast-dissolve disintegrating films (ODFs), melt in-mouth films, technologies can be divided into three oro-dispersible, quick dissolving and rapid broad groups: disintegrating films.[4,5] i. Lyophilized systems: The technology Advantages of Fast Dissolving Films [6] around these systems involves taking a • No risk of choking and obstruction. suspension or solution of drug with other • No need of water has led to better structural excipients, through the use of a acceptability amongst the dysphagic mould or blister pack, forming tablet- patients shaped units. The units or tablets are then • Improved oral bioavailability of drugs frozen and lyophilized in the pack or • Taste masking mould. The resulting units have a very high porosity, which allows rapid water • Enhanced stability or saliva penetration and very rapid • Improved patient compliance disintegration. • Oral films are flexible and they are not as ii. Compressed tablet-based systems: This fragile as most of the ODTs system is produced using standard tablet • Reduction in first pass metabolism may technology by direct compression of lead to reduction in the dose excipients. Depending on the method of • The oral or buccal mucosa is highly manufacture, the tablet technologies have vascularized, hence drugs can be different levels of hardness and friability. absorbed directly and can enter the The speed of disintegration for fast- systemic circulation without undergoing dissolve tablets compared with a standard first-pass hepatic metabolism tablet is achieved by formulating using Ideal Properties of Fast Dissolving either water soluble excipients, super- Films disintegrant or effervescent components, • It should have an acceptable taste. to allow rapid penetration of water into • It should give a pleasing mouth feel. the core of the tablet. • It should be less friable and have good iii. Thin film strips: Oral films, also called mechanical strength to withstand the post oral wafers, evolved over the past few manufacturing handling. years from the confection and oral care • It should be stable in environmental markets in the form of breath strips and conditions. became a novel and widely accepted form • Subsequent to oral administration, it by consumers for delivering vitamins and should leave least or no residue in mouth. personal care products. Today, FDFs are a • It should quickly dissolve to release drug proven and accepted technology for the instantaneously in mouth. systemic delivery of APIs for over-the- counter (OTC) medications and are in the • It should be compatible with the other early- to mid development stages for ingredients. prescription drugs. This has been Drug Selection Criteria for Fast attributed to the success of the breath Dissolving Films[7] freshener products by consumers such as • The drug should have pleasant taste. Listerine Pocket Paks in the US consumer 15 Available online at www.ijpras.com market. Such systems use a variety of iii. Plasticizers: Plasticizer is a vital ingredient hydrophilic polymers to produce a 50- of the oral films. The selection of plasticizer 200 mm film. The film is manufactured depends upon its compatibility with the as a large sheet and then cut into polymer and also the type of solvent employed individual dosage units for packaging in a in the casting of film. It helps to improve the range of pharmaceutically acceptable flexibility of the film and reduces the formats. brittleness of the film . Plasticizer significantly improves the strip properties by reducing the Formulation Aspects for Fast Dissolving glass transition temperature of the polymer. Films [7] Typically the plasticizers are used in the 1) Drug Category concentration of 1 - 20%w/w of dry polymer 2) Film Forming Polymers weight. Examples include: Glycerol, Propylene 3) Plasticizers glycol, Low molecular weight polyethylene 4) Sweetening Agents glycols, Citrate derivatives like triacetin, acetyl 5) Saliva Stimulating Agents citrate, Phthalate derivatives like dimethyl, 6) Cooling Agent diethyl, dibutyl derivatives, Castor oil etc. 7) Flavoring Agent iv. Sweetening agents: Sweeteners have 8) Coloring Agent become the important part of the food products 9) Surfactants as well as pharmaceutical products intended to 10) Stabilizing and thickening agents be disintegrated or dissolved in the oral cavity. Formulation of FDFs involves the intricate The sweet taste in formulation is more application of aesthetic and performance important in case of pediatric
Recommended publications
  • AP Suspension and Powder

    AP Suspension and Powder

    AP Suspension and Powder • Easily application and distribution • Ultrafine surface • Excellent stability Struers AP Suspensions and Powders are based on ultra pure aluminium oxides (alumina). They are available in two forms, Struers ApS deagglomerated and agglomerated. Pederstrupvej 84 DK-2750 Ballerup, Denmark Phone +45 44 600 800 Fax +45 44 600 801 [email protected] www.struers.com AUSTRALIAN & NEW ZEALAND NETHERLANDS Struers Australia Struers GmbH Nederland 27 Mayneview Street Zomerdijk 34 A Milton QLD 4064 3143 CT Maassluis Australia Telefoon +31 (10) 599 7209 Phone +61 7 3512 9600 Fax +31 (10) 5997201 Fax +61 7 3369 8200 [email protected] [email protected] NORWAY BELGIUM (Wallonie) Struers ApS, Norge Deagglomerated Agglomerated Struers S.A.S. Sjøskogenveien 44C 370, rue du Marché Rollay 1407 Vinterbro F- 94507 Champigny Telefon +47 970 94 285 Deagglomerated sur Marne Cedex [email protected] Téléphone +33 1 5509 1430 AP-D, deagglomerated aluminas are premium polishing abrasive and are agglomerate-free. The uniform Télécopie +33 1 5509 1449 AUSTRIA [email protected] Struers GmbH crystals ensure an ultrafine surface. Zweigniederlassung BELGIUM (Flanders) Österreich Struers GmbH Nederland Betriebsgebiet Puch Nord 8 Agglomerated Zomerdijk 34 A 5412 Puch 3143 CT Maassluis Telefon +43 6245 70567 AP-A, agglomerated aluminas are easily broken down during the polishing process while still providing Telefoon +31 (10) 599 7209 Fax +43 6245 70567-78 Fax +31 (10) 5997201 [email protected] faster initial stock removal. [email protected] POLAND CANADA Struers Sp. z o.o. Alumina powders Struers Ltd. Oddział w Polsce 7275 West Credit Avenue ul. Jasnogórska 44 Alumina powders consist of uniform particles with a narrow particle size distribution.
  • Study Protocol and Statistical Analysis Plan

    Study Protocol and Statistical Analysis Plan

    The University of Texas Southwestern Medical Center at Dallas Institutional Review Board PROJECT SUMMARY Study Title: Ultrasound-guided fascia iliaca compartment block versus periarticular infiltration for pain management after total hip arthroplasty: a randomized controlled trial Principal Investigator: Irina Gasanova, MD Sponsor/Funding Source: Department of Anesthesiology and Pain Management, UT Southwestern Medical School IRB Number: STU 122015-022 NCT Number: NCT02658240 Date of Document: 01 April 2016 Page 1 of 7 Purpose: In this randomized, controlled, observer-blinded study we plan to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty (THA). Background: Despite substantial advances in our understanding of the pathophysiology of pain and availability of newer analgesic techniques, postoperative pain is not always effectively treated (1). Optimal pain management technique balances pain relief with concerns about safety and adverse effects associated with analgesic techniques. Currently, postoperative pain is commonly treated with systemic opioids, which are associated with numerous adverse effects including nausea and vomiting, dizziness, drowsiness, pruritus, urinary retention, and respiratory depression (2). Use of regional and local anesthesia has been shown to reduce opioid requirements and opioid-related side effects. Therefore, their use has been emphasized (3, 4, 5, 6). Fascia Iliaca compartment block (FICB) is a field block that blocks the nerves from the lumbar plexus supplying the thigh (i.e., lateral femoral cutaneous femoral and obturator nerves). The obturator nerve is sometimes involved in the FICB but probably plays little role in postoperative pain relief for most surgeries of the hip and proximal femur.
  • Intravenous Therapy Procedure Manual

    Intravenous Therapy Procedure Manual

    INTRAVENOUS THERAPY PROCEDURE MANUAL - 1 - LETTER OF ACCEPTANCE __________________________________________ hereby approves (Facility) the attached Reference Manual as of _____________________. (Date) The Intravenous Therapy Procedure Manual will be reviewed at least annually or more often when deemed appropriate. Revisions will be reviewed as they occur. Current copies of the Intravenous Therapy Procedure Manual shall be maintained at each appropriate nursing station. I have reviewed this manual and agree to its approval. __________________________ (Administrator) __________________________ (Director of Nursing) __________________________ (Medical Director) - 2 - TABLE OF CONTENTS TABLE OF CONTENTS INTRODUCTION A. Purpose 1 B. Local Standard of Practice 1 RESPONSIBILITIES A. Responsibilities: M Chest Pharmacy 1 B. Responsibilities: Administrator 1 C. Responsibilities: Director of Nursing Services (DON/DNS) 1 D. Skills Validation 2 AMENDMENTS GUIDELINES A. Resident Candidacy for IV Therapy 1 B. Excluded IV Medications and Therapies 1 C. Processing the IV Order 1 D. IV Solutions/Medications: Storage 2 E. IV Solutions/Medications: Handling 3 F. IV Solutions and Supplies: Destroying and Returning 4 G. IV Tubing 5 H. Peripheral IV Catheters and Needles 6 I. Central Venous Devices 7 J. Documentation and Monitoring 8 K. IV Medication Administration Times 9 L. Emergency IV Supplies 10 I TABLE OF CONTENTS PROTOCOLS A. IV Antibiotic 1 1. Purpose 2. Guidelines 3. Nursing Responsibilities B. IV Push 2 1. Purpose 2. Guidelines C. Anaphylaxis Allergic Reaction 4 1. Purpose 2. Guidelines 3. Nursing Responsibilities and Interventions 4. Signs and Symptoms of Anaphylaxis 5. Drugs Used to Treat Anaphylaxis 6. Physician Protocol PRACTICE GUIDELINES A. Purpose 1 B. Personnel 1 C. Competencies 1 D.
  • Gel-Syn™ Product Information Caution

    Gel-Syn™ Product Information Caution

    GEL-SYN™ PRODUCT INFORMATION CAUTION: Federal law restricts this device to sale by or on the order of a physician (or properly licensed practitioner). CONTENT Each 1 mL of Gel-Syn contains: Sodium Hyaluronate: 8.4 mg Sodium Chloride: 8.5 mg Sodium Phosphate, Dibasic: 0.16 mg Sodium Phosphate, Monobasic: 0.045 mg Water for Injection: q.s. to 1.0 mL DESCRIPTION Gel-Syn is a sterile, buffered solution of highly purified sodium hyaluronate with a molecular weight of approximately 1100 kDa, obtained through fermentation of Streptococci of Lancefield groups A and C and chemically unmodified. INDICATION Gel-Syn is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). CONTRAINDICATIONS • Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. • Do not inject Gel-Syn into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site. WARNINGS • Do not concomitantly use disinfectants containing quaternary ammonium salts for skin preparation because sodium hyaluronate can precipitate in their presence. • Inject into the synovial space only. Do not inject by intravascular route. • Do not inject outside the synovial space or into the synovial tissue or capsule. An extra- articular injection of the product can cause local adverse events. PRECAUTIONS General • The safety and effectiveness of Gel-Syn in locations other than the knee, and for conditions other than osteoarthritis, have not been established. • Strict aseptic administration technique must be followed.
  • Physical-Chemical Characteristics of Whitening Toothpaste and Evaluation of Its Effects on Enamel Roughness

    Physical-Chemical Characteristics of Whitening Toothpaste and Evaluation of Its Effects on Enamel Roughness

    Dental materials Physical-chemical characteristics of whitening toothpaste and evaluation of its effects on enamel roughness Sérgio Paulo Hilgenberg(a) Abstract: This in vitro study evaluated the physical-chemical characteris- (a) Shelon Cristina Souza Pinto tics of whitening toothpastes and their effect on bovine enamel after ap- Paulo Vitor Farago(b) Fábio André Santos(a) plication of a bleaching agent (16% carbamide peroxide). Physical-chem- Denise Stadler Wambier(a) ical analysis was made considering mass loss by desiccation, ash content and pH of the toothpastes. Thirty bovine dental enamel fragments were prepared for roughness measurements. The samples were subjected to (a) Department of Dentistry, School of Dentistry, Ponta Grossa State University, bleaching treatments and simulated brushing: G1. Sorriso Dentes Brancos Ponta Grossa, PR, Brazil. (Conventional toothpaste), G2. Close-UP Whitening (Whitening tooth- (b) Department of Pharmacy, School of paste), and G3. Sensodyne Branqueador (Whitening toothpaste). The av- Dentistry, Ponta Grossa State University, erage roughness (Ra) was evaluated prior to the bleaching treatment and Ponta Grossa, PR, Brazil. after brushing. The results revealed differences in the physical-chemical characteristics of the toothpastes (p < 0.0001). The final Ra had higher values (p < 0.05) following the procedures. The mean of the Ra did not show significant differences, considering toothpaste groups and bleach- ing treatment. Interaction (toothpaste and bleaching treatment) showed significant difference
  • An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review

    An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review

    Muthadi Radhika Reddy /J. Pharm. Sci. & Res. Vol. 12(7), 2020, 925-940 An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review Muthadi Radhika Reddy1* 1School of pharmacy, Gurunanak Institute of Technical Campus, Hyderabad, Telangana, India and Department of Pharmacy, Gandhi Institute of Technology and Management University, Vizag, Andhra Pradesh, India INTRODUCTION 2. Useful in situations where rapid onset of action Fast dissolving drug delivery systems were first developed required such as in motion sickness, allergic attack, in the late 1970s as an alternative to conventional dosage coughing or asthma forms. These systems consist of solid dosage forms that 3. Has wide range of applications in pharmaceuticals, Rx disintegrate and dissolve quickly in the oral cavity without Prescriptions and OTC medications for treating pain, the need of water [1]. Fast dissolving drug delivery cough/cold, gastro-esophageal reflux disease,erectile systems include orally disintegrating tablets (ODTs) and dysfunction, sleep disorders, dietary supplements, etc oral thin films (OTFs). The Centre for Drug Evaluation [4] and Research (CDER) defines ODTs as,“a solid dosage 4. No water is required for the administration and hence form containing medicinal substances which disintegrates suitable during travelling rapidly, usually within a matter of seconds, when placed 5. Some drugs are absorbed from the mouth, pharynx upon the tongue” [2]. USFDA defines OTFs as, “a thin, and esophagus as the saliva passes down into the flexible, non-friable polymeric film strip containing one or stomach, enhancing bioavailability of drugs more dispersed active pharmaceutical ingredients which is 6. May offer improved bioavailability for poorly water intended to be placed on the tongue for rapid soluble drugs by offering large surface area as it disintegration or dissolution in the saliva prior to disintegrates and dissolves rapidly swallowing for delivery into the gastrointestinal tract” [3].
  • Acrylamide Polymerization — a Practical Approach

    Acrylamide Polymerization — a Practical Approach

    electrophoresis tech note 1156 Acrylamide Polymerization — A Practical Approach Paul Menter, Bio-Rad Laboratories, 2000 Alfred Nobel Drive, Polyacrylamide Gel Polymerization Hercules, CA 94547 USA AcrylamideBis Polyacrylamide Introduction The unparalleled resolution and flexibility possible with CH2 CH + CH2 CH CH2 CH CH2 CH CH2 CH polyacrylamide gel electrophoresis (PAGE) has led to its CO CO CO CO CO widespread use for the separation of proteins and nucleic NH2 NH NH2 NH2 NH acids. Gel porosity can be varied over a wide range to meet CH2 CH2 specific separation requirements. Electrophoresis gels and NH NH NH NH buffers can be chosen to provide separation on the basis of CO 2 2 CO CO C O charge, size, or a combination of charge and size. CH2 CH CH2 CH CH2 CH CH2 CH The key to mastering this powerful technique lies in the polymerization process itself. By understanding the important Purity of Gel-Forming Reagents parameters, and following a few simple guidelines, the novice Acrylamide can become proficient and the experienced user can optimize Gel-forming reagents include the monomers, acrylamide and bis, separations even further. as well as the initiators, usually ammonium persulfate and TEMED or, occasionally, riboflavin and TEMED. On a molar This bulletin takes a practical approach to the preparation of basis, acrylamide is by far the most abundant component in the polyacrylamide gels. Its purpose is to provide the information monomer solution. As a result, acrylamide may be the primary required to achieve reproducible, controllable polymerization. source of interfering contaminants (Dirksen and Chrambach For those users interested only in the “bare essentials,” the 1972).
  • Sucralfate Enemas

    Sucralfate Enemas

    Sucralfate Enemas Sucralfate enemas are used to treat inflammation of the rectum (the lower part of the large intestine leading to the anus); most commonly this is for radiation proctitis; bowel inflammation following radiotherapy. This treatment can help treat bleeding due to the inflammation, and can be continued for up to 24 weeks; you can stop when the bleeding stops. This fact sheet explains how you can administer the enema yourself, using a syringe and catheter. The hospital or community pharmacy can provide the Sucralfate enema, and you will need to ask your GP or practise nurse to supply the equipment you will need. Your practise nurse can help you practice preparing the enema, and could help you with administering it at home, if you find this difficult. 1. Using the syringe provided, draw up 10mls of the Sucralfate Suspension (2g) and then draw up 10mls of warm water and mix. Ensure that any excess air is expelled from the syringe. 2. Attach the catheter provided to the syringe tip and lubricate the end of the catheter with lubricating gel provided. 3. Lie on your left side with both knees bent. This position will help the flow of liquid in to the rectum and aid enema retention. 4. Position a towel underneath yourself to catch any leakage of fluid once the enema has been administered. 5. With a steady pressure, gently insert the catheter to a depth of approximately 10cm into the rectum. 6. Press down on the barrel of the syringe slowly, using a steady and even pressure, until the entire contents of the syringe have been administered.
  • An Overview On: Sublingual Route for Systemic Drug Delivery

    An Overview On: Sublingual Route for Systemic Drug Delivery

    International Journal of Research in Pharmaceutical and Biomedical Sciences ISSN: 2229-3701 __________________________________________Review Article An Overview on: Sublingual Route for Systemic Drug Delivery K. Patel Nibha1 and SS. Pancholi2* 1Department of Pharmaceutics, BITS Institute of Pharmacy, Gujarat Technological university, Varnama, Vadodara, Gujarat, India 2BITS Institute of Pharmacy, Gujarat Technological University, Varnama, Vadodara, Gujarat, India. __________________________________________________________________________________ ABSTRACT Oral mucosal drug delivery is an alternative and promising method of systemic drug delivery which offers several advantages. Sublingual literally meaning is ''under the tongue'', administrating substance via mouth in such a way that the substance is rapidly absorbed via blood vessels under tongue. Sublingual route offers advantages such as bypasses hepatic first pass metabolic process which gives better bioavailability, rapid onset of action, patient compliance , self-medicated. Dysphagia (difficulty in swallowing) is common among in all ages of people and more in pediatric, geriatric, psychiatric patients. In terms of permeability, sublingual area of oral cavity is more permeable than buccal area which is in turn is more permeable than palatal area. Different techniques are used to formulate the sublingual dosage forms. Sublingual drug administration is applied in field of cardiovascular drugs, steroids, enzymes and some barbiturates. This review highlights advantages, disadvantages, different sublingual formulation such as tablets and films, evaluation. Key Words: Sublingual delivery, techniques, improved bioavailability, evaluation. INTRODUCTION and direct access to systemic circulation, the oral Drugs have been applied to the mucosa for topical mucosal route is suitable for drugs, which are application for many years. However, recently susceptible to acid hydrolysis in the stomach or there has been interest in exploiting the oral cavity which are extensively metabolized in the liver.
  • Vaccine Administration Joellen Wolicki, BSN, RN and Elaine Miller, RN, BSN, MPH

    Vaccine Administration Joellen Wolicki, BSN, RN and Elaine Miller, RN, BSN, MPH

    Vaccine Administration JoEllen Wolicki, BSN, RN and Elaine Miller, RN, BSN, MPH This chapter summarizes best practices related to vaccine administration, a key factor in ensuring vaccination is as safe NOTES and effective as possible. Administration involves a series of actions: assessing patient vaccination status and determining needed vaccines, screening for contraindications and precautions, educating patients, preparing and administering vaccines properly, and documenting the vaccines administered. Professional standards for medication administration, manufacturer instructions, and organizational policies and procedures should always be followed when applicable. 6 Staff Training and Education Policies should be in place to validate health care professionals’ knowledge of, and skills in, vaccine administration. All health care professionals should receive comprehensive, competency- based training before administering vaccines. Training, including an observation component, should be integrated into health care professionals’ education programs including orientation for new staff and annual continuing education requirements for all staff. In addition, health care professionals should receive educational updates as needed, such as when vaccine administration recommendations are updated or when new vaccines are added to the facility’s inventory. Training should also be offered to temporary staff who may be filling in on days when the facility is short-staffed or helping during peak periods of vaccine administration such as influenza season. Once initial training has been completed, accountability checks should be in place to ensure staff follow all vaccine administration policies and procedures. Before Administering Vaccine Health care professionals should be knowledgeable about appropriate techniques to prepare and care for patients when administering vaccines. Assess for Needed Vaccines The patient’s immunization status should be reviewed at every health care visit.
  • Liposome-Based Drug Delivery Systems in Cancer Immunotherapy

    Liposome-Based Drug Delivery Systems in Cancer Immunotherapy

    pharmaceutics Review Liposome-Based Drug Delivery Systems in Cancer Immunotherapy Zili Gu 1 , Candido G. Da Silva 1 , Koen van der Maaden 2,3, Ferry Ossendorp 2 and Luis J. Cruz 1,* 1 Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands 2 Tumor Immunology Group, Department of Immunology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands 3 TECOdevelopment GmbH, 53359 Rheinbach, Germany Received: 1 October 2020; Accepted: 2 November 2020; Published: 4 November 2020 Abstract: Cancer immunotherapy has shown remarkable progress in recent years. Nanocarriers, such as liposomes, have favorable advantages with the potential to further improve cancer immunotherapy and even stronger immune responses by improving cell type-specific delivery and enhancing drug efficacy. Liposomes can offer solutions to common problems faced by several cancer immunotherapies, including the following: (1) Vaccination: Liposomes can improve the delivery of antigens and other stimulatory molecules to antigen-presenting cells or T cells; (2) Tumor normalization: Liposomes can deliver drugs selectively to the tumor microenvironment to overcome the immune-suppressive state; (3) Rewiring of tumor signaling: Liposomes can be used for the delivery of specific drugs to specific cell types to correct or modulate pathways to facilitate better anti-tumor immune responses; (4) Combinational therapy: Liposomes are ideal vehicles for the simultaneous delivery of drugs to be combined with other therapies, including chemotherapy, radiotherapy, and phototherapy. In this review, different liposomal systems specifically developed for immunomodulation in cancer are summarized and discussed. Keywords: liposome; drug delivery; cancer immunotherapy; immunomodulation 1. The Potential of Immunotherapy for the Treatment of Cancer Cancer immunotherapy has been widely explored because of its durable and robust effects [1].
  • Intra-Luminal Focused Ultrasound for Augmentation of Gastrointestinal Drug Delivery

    Intra-Luminal Focused Ultrasound for Augmentation of Gastrointestinal Drug Delivery

    Editorial Page 1 of 2 Intra-luminal focused ultrasound for augmentation of gastrointestinal drug delivery Ezekiel Maloney1, Joo Ha Hwang2 1Department of Radiology, 2Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, WA, USA Correspondence to: Joo Ha Hwang, MD, PhD. Division of Gastroenterology, Department of Medicine, University of Washington, Box 359773, 325 Ninth Avenue, Seattle, WA 98104, USA. Email: [email protected]. Provenance: This is a Guest Editorial commissioned by Section Editor Hui Kong, MD, PhD (Department of Respiratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China). Comment on: Schoellhammer CM, Schroeder A, Maa R, et al. Ultrasound-mediated gastrointestinal drug delivery. Sci Transl Med 2015;7:310ra168. Submitted Feb 01, 2017. Accepted for publication Feb 06, 2017. doi: 10.21037/atm.2017.03.42 View this article at: http://dx.doi.org/10.21037/atm.2017.03.42 The recent article by Schoellhammer et al., “Ultrasound- intensity ultrasound frequencies followed by quantification mediated gastrointestinal drug delivery” primarily of delivery of permeants (e.g., glucose, dextran, insulin). addresses practical limitations in drug delivery for medical Treated tissues showed enhanced transport. Similar management of inflammatory bowel disease (IBD), and findings were demonstrated in small and large bowel tissue presents pre-clinical data demonstrating that intra- for radiolabeled mesalamine and hydrocortisone. With 1 luminal, sub-ablative focused ultrasound (FUS), delivered minute of ultrasound treatment time, 3–5-fold improved via a trans-rectal transducer, can overcome some of these drug delivery was observed versus control. Additional limitations (1). The clinical application and benefit of such a ex vivo experiments utilizing variable FUS protocols to device is clear.